Top 50 Aspiriant LLC Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| IVV | ISHARES TR | 15.91% | 860.6K | $644.5M | +30.03%(+198.74K) | $537.64(+44.88%) | 2026-06-30 | |
| VBR | VANGUARD INDEX FDS | 10.47% | 1.75M | $424.2M | +0.35%(+6.01K) | $171.36(+46.18%) | 2026-06-30 | |
| IUSV | ISHARES TR | 10.02% | 3.69M | $406.0M | +0.07%(+2.45K) | $68.74(+67.82%) | 2026-06-30 | |
| ACWV | ISHARES INC | 7.22% | 2.43M | $292.5M | -0.23%(-5.62K) | $86.23(+47.00%) | 2026-06-30 | |
| VIG | VANGUARD SPECIALIZED FUNDS | 5.58% | 955.0K | $226.0M | -0.01%(-102) | $126.75(+93.35%) | 2026-06-30 | |
| VTEB | VANGUARD MUN BD FDS | 5.34% | 4.27M | $216.1M | +0.92%(+38.86K) | $50.25(-1.08%) | 2026-06-30 | |
| VOO | VANGUARD INDEX FDS | 3.07% | 181.2K | $124.5M | +0.03%(+48) | $308.44(+131.06%) | 2026-06-30 | |
| IEFA | ISHARES TR | 2.41% | 1.01M | $97.6M | +2.42%(+23.92K) | $74.72(+35.59%) | 2026-06-30 | |
| IEMG | ISHARES INC | 2.18% | 1.07M | $88.5M | -0.37%(-3.97K) | $52.06(+58.72%) | 2026-06-30 | |
| EFV | ISHARES TR | 2.01% | 1.06M | $81.2M | -0.79%(-8.47K) | $42.56(+92.16%) | 2026-06-30 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative | 5-Year Annualized | 5-Year Cumulative |
|---|---|---|---|---|
| Top 20 Holdings Weighted | +11.54% | +38.75% | +5.86% | +32.94% |
| Top 20 Holdings Unweighted | +12.36% | +41.84% | +6.05% | +34.14% |
Aspiriant LLC reports $4.05B in US-listed equity holdings across 400 positions in its most recent 13F filing. Its largest disclosed positions are IVV (15.9%), VBR (10.5%) and IUSV (10.0%). The top 20 holdings account for 74.91% of reported assets. Its disclosed equity book has returned +38.75% on a three-year cumulative basis. Figures reflect the Q2 2026 filing.
Portfolio changes
Every reported change this quarter, grouped by direction. The signal is in the rotation, not any single trade.
Sign up free to track Aspiriant LLC, compare funds side by side, and get alerts the moment positions change.
Holdings on this page are parsed from Aspiriant LLCโs Form 13F filings with the U.S. Securities and Exchange Commission (CIK 1433541). View Aspiriant LLCโs 13F filings on SEC